Bank of America’s AbbVie ABBV Stock Holding History

Bank of America’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$5.21B	Sell	23,936,943 -1,887,456	-7%	-$419M	0.38%	48
2025 Q4	$5.9B	Buy	25,824,399 +669,494	+3%	+$153M	0.43%	39
2025 Q3	$5.82B	Buy	25,154,905 +45,260	+0.2%	+$9.22M	0.4%	45
2025 Q2	$4.66B	Sell	25,109,645 -2,843,885	-10%	-$529M	0.34%	52
2025 Q1	$5.86B	Buy	27,953,530 +2,629,565	+10%	+$511M	0.47%	38
2024 Q4	$4.5B	Buy	25,323,965 +4,383,302	+21%	+$806M	0.38%	50
2024 Q3	$4.14B	Buy	20,940,663 +300,907	+1%	+$56.2M	0.33%	54
2024 Q2	$3.54B	Buy	20,639,756 +915,221	+5%	+$152M	0.31%	63
2024 Q1	$3.59B	Buy	19,724,535 +1,124,582	+6%	+$194M	0.33%	63
2023 Q4	$2.88B	Sell	18,599,953 -595,612	-3%	-$86.8M	0.29%	74
2023 Q3	$2.86B	Buy	19,195,565 +939,385	+5%	+$138M	0.32%	70
2023 Q2	$2.46B	Sell	18,256,180 -2,451,672	-12%	-$360M	0.26%	82
2023 Q1	$3.3B	Buy	20,707,852 +726,693	+4%	+$111M	0.34%	61
2022 Q4	$3.23B	Buy	19,981,159 +75,245	+0.4%	+$11.5M	0.37%	54
2022 Q3	$2.67B	Sell	19,905,914 -1,147,545	-5%	-$165M	0.32%	66
2022 Q2	$3.22B	Buy	21,053,459 +1,191,947	+6%	+$182M	0.37%	54
2022 Q1	$3.22B	Sell	19,861,512 -533,260	-3%	-$77.5M	0.31%	67
2021 Q4	$2.76B	Buy	20,394,772 +277,399	+1%	+$32.8M	0.27%	83
2021 Q3	$2.17B	Buy	20,117,373 +1,213,108	+6%	+$139M	0.22%	96
2021 Q2	$2.13B	Buy	18,904,265 +202,423	+1%	+$22.8M	0.22%	97
2021 Q1	$2.02B	Buy	18,701,842 +793,968	+4%	+$84.9M	0.23%	97
2020 Q4	$1.92B	Sell	17,907,874 -299,782	-2%	-$28.8M	0.25%	102
2020 Q3	$1.59B	Buy	18,207,656 +714,905	+4%	+$67.3M	0.22%	111
2020 Q2	$1.72B	Buy	17,492,751 +2,310,883	+15%	+$203M	0.26%	96
2020 Q1	$1.16B	Buy	15,181,868 +2,206,867	+17%	+$188M	0.21%	114
2019 Q4	$1.15B	Sell	12,975,001 -850,618	-6%	-$70.6M	0.16%	133
2019 Q3	$1.05B	Sell	13,825,619 -580,939	-4%	-$39.8M	0.16%	139
2019 Q2	$1.05B	Sell	14,406,558 -507,805	-3%	-$39.9M	0.16%	144
2019 Q1	$1.2B	Sell	14,914,363 -928,031	-6%	-$75.9M	0.19%	131
2018 Q4	$1.46B	Sell	15,842,394 -4,640,836	-23%	-$408M	0.26%	91
2018 Q3	$1.94B	Buy	20,483,230 +208,054	+1%	+$19.7M	0.3%	71
2018 Q2	$1.88B	Sell	20,275,176 -2,367,175	-10%	-$231M	0.31%	70
2018 Q1	$2.14B	Buy	22,642,351 +5,811,003	+35%	+$638M	0.37%	60
2017 Q4	$1.63B	Sell	16,831,348 -2,906,144	-15%	-$274M	0.27%	87
2017 Q3	$1.75B	Buy	19,737,492 +1,717,988	+10%	+$131M	0.28%	84
2017 Q2	$1.31B	Sell	18,019,504 -840,594	-4%	-$56.5M	0.26%	96
2017 Q1	$1.23B	Buy	18,860,098 +12,072	+0.1%	+$759K	0.24%	102
2016 Q4	$1.18B	Sell	18,848,026 -408,358	-2%	-$24.9M	0.26%	91
2016 Q3	$1.21B	Sell	19,256,384 -11,867,399	-38%	-$768M	0.27%	88
2016 Q2	$1.93B	Buy	31,123,783 +162,658	+0.5%	+$9.91M	0.45%	48
2016 Q1	$1.77B	Buy	30,961,125 +3,469,955	+13%	+$193M	0.43%	48
2015 Q4	$1.63B	Buy	27,491,170 +317,766	+1%	+$18.3M	0.39%	49
2015 Q3	$1.48B	Buy	27,173,404 +8,431,402	+45%	+$549M	0.37%	54
2015 Q2	$1.26B	Buy	18,742,002 +760,222	+4%	+$49.6M	0.41%	41
2015 Q1	$1.05B	Buy	17,981,780 +2,990,794	+20%	+$181M	0.35%	51
2014 Q4	$981M	Sell	14,990,986 -5,794,980	-28%	-$365M	0.35%	44
2014 Q3	$1.2B	Buy	20,785,966 +1,059,033	+5%	+$58.8M	0.39%	47
2014 Q2	$1.11B	Buy	19,726,933 +934,981	+5%	+$49.1M	0.36%	51
2014 Q1	$966M	Buy	18,791,952 +235,298	+1%	+$11.9M	0.36%	52
2013 Q4	$980M	Sell	18,556,654 -1,242,657	-6%	-$61.1M	0.35%	51
2013 Q3	$886M	Buy	19,799,311 +1,193,643	+6%	+$52.9M	0.35%	48
2013 Q2	$769M	Buy	+18,605,668	New	+$814M	0.32%	57

Other funds holding ABBV

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Bank of America's ABBV Position: Q1 2026 in Review

Bank of America reduced its AbbVie (ABBV) stake by 7.3% in Q1 2026, selling an estimated $419M and leaving 23,936,943 shares worth $5.21B. The position accounts for 0.38% of the portfolio, ranked #48.

Bank of America first reported a position in ABBV in Q2 2013 and has held it in 52 quarters since. The position peaked at $5.9B in Q4 2025. 4,080 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

Bank of America held 23,936,943 shares of AbbVie worth $5.21B as of Q1 2026.
Bank of America sold 1,887,456 AbbVie shares in Q1 2026, an estimated $419M.
AbbVie made up 0.38% of Bank of America's portfolio in Q1 2026, its #48 holding.
Bank of America first reported a position in AbbVie in Q2 2013 and has held it in 52 quarters since.
Bank of America's AbbVie position peaked at $5.9B in Q4 2025.
4,080 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on Bank of America's 13F filing for Q1 2026, filed 18 May 2026.